Clinical Trials Browser

Lung Neoplasms

NCT01647425 2026-03-16

ALTAK

Completed

385 enrolled

Head & NeckThoracic

Alcoholism, Head and Neck Neoplasms, Lung Neoplasms, Tobacco Use Disorder

NCT02540174 2026-03-13

ALTAKRA-1405

Phase NA Completed

133 enrolled

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Tobacco Use

NCT06052449 2026-03-11

Assessing Social Determinants of Health to Increase Cancer Screening

Phase NA Completed

101 enrolled 22 charts

Thoracic

Lung Neoplasms

NCT07441863 2026-03-11

Structured Pulmonary Physiotherapy After Lung Cancer Surgery by Age Group

Phase NA Completed

60 enrolled

Thoracic

Lung Neoplasms

NCT07451756 2026-03-05

Effects of Pranayama Breathing Technique on Stress Level, Sleep Quality, and Quality of Life Among Older Adults

Phase NA Completed

74 enrolled

Thoracic

Sleep Initiation and Maintenance Disorders, Lung Neoplasms

NCT06955468 2026-03-04

Prime GOC

Phase NA Completed

40 enrolled

GastrointestinalThoracic

Communication, Gastrointestinal Neoplasms, Lung Neoplasms

NCT04798664 2026-02-25

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Phase NA Completed

3,228 enrolled 41 charts

Thoracic

Lung Neoplasms, Tobacco Use Disorder, Smoking Cessation

NCT03724331 2026-02-24

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

Phase NA Completed

235 enrolled 17 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms, Motor Activity

NCT06361121 2026-02-23

Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy

Phase NA Completed

180 enrolled

Thoracic

Bronchiectasis, Lung Neoplasms

NCT04738487 2026-02-20

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

Phase 3 Completed

1,264 enrolled 16 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06000683 2026-02-20

Empower-LCS

Phase NA Completed

79 enrolled 20 charts

Thoracic

Lung Neoplasms

NCT06912113 2026-02-20

The Effect of Motivational ınterviewing on ıntention to Quit Smoking in Lung Cancer Patients

Phase NA Completed

42 enrolled

Thoracic

Lung Neoplasms, Smoking Cessation

NCT02513563 2026-02-19

AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

Phase 2 Completed

42 enrolled 12 charts

Thoracic

Lung Neoplasms

NCT00340405 2026-02-17

Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China

Completed

9,759 enrolled

Thoracic

Lung Neoplasms

Clinical Trials

Lung Cancer Risk Assessment and Etiology

ALTAK

ALTAKRA-1405

Assessing Social Determinants of Health to Increase Cancer Screening

Structured Pulmonary Physiotherapy After Lung Cancer Surgery by Age Group

Effects of Pranayama Breathing Technique on Stress Level, Sleep Quality, and Quality of Life Among Older Adults

Prime GOC

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

Empower-LCS

The Effect of Motivational ınterviewing on ıntention to Quit Smoking in Lung Cancer Patients

AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer

Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China